Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Hepatitis B Antibodies in Children
NCT00356564Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Infanrix Hexa in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentration. Started Jul 2006; status: completed.
02
Drugs
Infanrix Hexa
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00356564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356564.